Cargando…
Identifying biosimilar side effects: Infliximab-dyyb-associated subcorneal pustular dermatosis
Autores principales: | Gozo, Maria Amoreth R., Manalo, Iviensan F., Cornelius, Tunisia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243164/ https://www.ncbi.nlm.nih.gov/pubmed/34222604 http://dx.doi.org/10.1016/j.ijwd.2020.12.004 |
Ejemplares similares
-
Successful treatment of refractory Sneddon‐Wilkinson disease (subcorneal pustular dermatosis) with infliximab
por: Romagnuolo, Maurizio, et al.
Publicado: (2022) -
Subcorneal pustular dermatosis masquerading as dermatophytosis
por: Thomas, Jayakar, et al.
Publicado: (2012) -
Subcorneal pustular dermatosis in the pediatric age
por: Jardim, Márcio Martins Lobo, et al.
Publicado: (2018) -
Successful Treatment of Severe Subcorneal Pustular Dermatosis with Adalimumab
por: Chen, Jiaoquan, et al.
Publicado: (2022) -
Mycoplasma Pneumoniae-associated Subcorneal Pustular Dermatosis: Not as Rare as We Think?
por: Baeza-Hernández, Gloria, et al.
Publicado: (2022)